BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6992574)

  • 1. Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes.
    Vincenti F; Amend W; Feduska NJ; Duca RM; Salvatierra O
    Am J Med; 1980 Jul; 69(1):107-12. PubMed ID: 6992574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of rejection on graft survival after renal transplantation.
    Lytton B; Finkelstein FO; Schiff M; Black HR
    Trans Am Assoc Genitourin Surg; 1975; 67():99-102. PubMed ID: 788307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid treatment for routine immunosuppression in cadaver renal transplantation. A survey of hospitals.
    Kumar P; Leech SH; Gonzalez FM; Kodlin D
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():90-2. PubMed ID: 386327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
    Novick AC; Khauli RB; Braun WE; Steinmuller D; Cunningham R; Buszta C; Goormastic M
    J Urol; 1984 Apr; 131(4):636-40. PubMed ID: 6368866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of rejection on graft survival after renal transplantation.
    Lytton B; Finkelstein FO; Schiff M; Black HR
    J Urol; 1976 Sep; 116(3):300-3. PubMed ID: 785028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine versus azathioprine: a review of 200 consecutive cadaver renal transplant recipients.
    Kropp KA; Wolfe C; Jhunjhunwala JS; Selman SH
    J Urol; 1989 Jul; 142(1):28-31. PubMed ID: 2659825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.
    Matas AJ; Kandaswamy R; Humar A; Payne WD; Dunn DL; Najarian JS; Gruessner RW; Gillingham KJ; McHugh LE; Sutherland DE
    Ann Surg; 2004 Sep; 240(3):510-6; discussion 516-7. PubMed ID: 15319722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors contributing to the declining mortality rate in renal transplantation.
    Tilney NL; Strom TB; Vineyard GC; Merrill JP
    N Engl J Med; 1978 Dec; 299(24):1321-5. PubMed ID: 101845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.
    Seikaly M; Ho PL; Emmett L; Tejani A
    Pediatr Transplant; 2001 Jun; 5(3):215-31. PubMed ID: 11422826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosage of corticosteroids in renal allograft rejection.
    Silberman H
    Am J Surg; 1981 Sep; 142(3):413-5. PubMed ID: 7025673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.